CIPHER Grant Programme
Applications for the 2019-2020 round are now closed
The CIPHER Grant Programme directly supports the development of early-stage investigators, awarding up to US$150,000 for up to two years to address research gaps in paediatric and adolescent HIV in resource-limited settings. This is a unique “stepping up” opportunity, designed to give investigators the experience they need to compete for larger funding. The grants are resulting in personal and career development, capacity building on the ground, and research that informs critical management and care and leads to policy change.
Since 2013, CIPHER Grantees have been addressing key clinical and operational research gaps in paediatric and adolescent HIV. And they are doing this where it is needed the most, in low- and middle-income countries (LMICs); in fact, recognizing the importance of building research capacity, approximately 80% of funds are awarded to applicants from LMICs. The intention is to attract early-stage investigators – from inside and outside the field of HIV research – to address critical research questions, while providing a unique opportunity for professional development.
CIPHER has partnered with the World Health Organization to develop global research agendas on HIV testing, treatment and service delivery for paediatric and adolescent populations. CIPHER implements these global research priorities as a funder through its grant and fellowship programmes.
The 2019/2020 round will focus on operational research in paediatric and adolescent HIV. This recognizes the need to advance research that could inform HIV policies and programmes, thus accelerating the HIV response in grantees’ countries.
This year, CIPHER is pleased to also accept applications in French, particularly to encourage more applications from young investigators in West and Central Africa. The aim is to support the HIV response in the region, which bears one of the heaviest HIV burdens but is often neglected in global initiatives.
The CIPHER Grant Programme is made possible with the generous support of Founding Sponsor ViiV Healthcare and Janssen. Its content is guided by experts in paediatric and adolescent HIV convened by the IAS.
Find out more